Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243363494> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W4243363494 abstract "Abstract Background: Accumulating evidence points to epigenetic mechanisms as essential in tumorigenesis. Treatment that targets epigenetic regulators is becoming an attractive strategy for cancer therapy. The role of epigenetic therapy in prostate cancer (PCa) remains elusive. Previously we demonstrated a correlation of levels of histone lysine demethylase KDM4B with the appearance of castration resistant prostate cancer (CRPC) and identified a small molecular inhibitor of KDM4B, B3. In this study, we aim to define the role of KDM4B in promoting PCa progression and test the efficacy of B3 using clinically relevant PCa models. Methods: KDM4B was overexpressed in LNCaP cells or knocked down (KD) in 22Rv1 cells. The specificity of B3 was determined in vitro using recombinant KDM proteins and in vivo using 22Rv1 cell lysates. The efficacy of B3 monotherapy or in combination with androgen receptor (AR) antagonist enzalutamide or the mTOR inhibitor rapamycin was tested using xenograft models in castrated mice. Comparative transcriptomic analysis was performed on KDM4B KD and B3-treated 22Rv1 cells to determine the on-target (KDM4B-dependent) and off-target (non-KDM4B-associated) effects of B3. Results: Overexpression of KDM4B in LNCaP cells enhanced its tumorigenicity whereas knockdown of KDM4B in 22Rv1 cells reduced tumor growth in castrated mice. B3 suppressed the growth of both 22Rv1 and VCaP xenografts and sensitized 22Rv1 cells to enzalutamide inhibition. B3 also inhibited 22Rv1 tumor growth synergistically with rapamycin that resulted in cell apoptosis. Mechanistically, B3 inhibited expression of AR-V7 and genes involved in epithelial-to-mesenchymal transition. DNA replication stress marker γH2A.X was upregulated by B3, which is further increased when combined with rapamycin. Based on transcriptomic and biochemical analyses, B3 inhibits both H3K9me3 and H3K27me3 demethylase activity, which is believed to underlie its anti-tumor action. Conclusions: Our studies establish KDM4B as a potent target for CRPC and B3 as a potential therapeutic agent. B3 as monotherapy or in combination with other anti-PCa therapeutics offers proof of principle for the clinical translation of epigenetic therapy targeting KDMSs for CRPC patients." @default.
- W4243363494 created "2022-05-12" @default.
- W4243363494 creator A5002464705 @default.
- W4243363494 creator A5002719697 @default.
- W4243363494 creator A5003561140 @default.
- W4243363494 creator A5013331146 @default.
- W4243363494 creator A5020522663 @default.
- W4243363494 creator A5022324751 @default.
- W4243363494 creator A5027483673 @default.
- W4243363494 creator A5030131037 @default.
- W4243363494 creator A5036668774 @default.
- W4243363494 creator A5042645439 @default.
- W4243363494 creator A5044797315 @default.
- W4243363494 creator A5051435411 @default.
- W4243363494 creator A5052134746 @default.
- W4243363494 creator A5055129397 @default.
- W4243363494 creator A5069595062 @default.
- W4243363494 creator A5085071616 @default.
- W4243363494 creator A5086368014 @default.
- W4243363494 creator A5088408355 @default.
- W4243363494 creator A5090605165 @default.
- W4243363494 date "2021-10-11" @default.
- W4243363494 modified "2023-10-05" @default.
- W4243363494 title "Therapeutic Targeting of Histone Lysine Demethylase KDM4B Blocks the Growth of Castration-resistant Prostate Cancer" @default.
- W4243363494 doi "https://doi.org/10.21203/rs.3.rs-957516/v1" @default.
- W4243363494 hasPublicationYear "2021" @default.
- W4243363494 type Work @default.
- W4243363494 citedByCount "0" @default.
- W4243363494 crossrefType "posted-content" @default.
- W4243363494 hasAuthorship W4243363494A5002464705 @default.
- W4243363494 hasAuthorship W4243363494A5002719697 @default.
- W4243363494 hasAuthorship W4243363494A5003561140 @default.
- W4243363494 hasAuthorship W4243363494A5013331146 @default.
- W4243363494 hasAuthorship W4243363494A5020522663 @default.
- W4243363494 hasAuthorship W4243363494A5022324751 @default.
- W4243363494 hasAuthorship W4243363494A5027483673 @default.
- W4243363494 hasAuthorship W4243363494A5030131037 @default.
- W4243363494 hasAuthorship W4243363494A5036668774 @default.
- W4243363494 hasAuthorship W4243363494A5042645439 @default.
- W4243363494 hasAuthorship W4243363494A5044797315 @default.
- W4243363494 hasAuthorship W4243363494A5051435411 @default.
- W4243363494 hasAuthorship W4243363494A5052134746 @default.
- W4243363494 hasAuthorship W4243363494A5055129397 @default.
- W4243363494 hasAuthorship W4243363494A5069595062 @default.
- W4243363494 hasAuthorship W4243363494A5085071616 @default.
- W4243363494 hasAuthorship W4243363494A5086368014 @default.
- W4243363494 hasAuthorship W4243363494A5088408355 @default.
- W4243363494 hasAuthorship W4243363494A5090605165 @default.
- W4243363494 hasBestOaLocation W42433634941 @default.
- W4243363494 hasConcept C104317684 @default.
- W4243363494 hasConcept C121608353 @default.
- W4243363494 hasConcept C2776551883 @default.
- W4243363494 hasConcept C2776745794 @default.
- W4243363494 hasConcept C2779723316 @default.
- W4243363494 hasConcept C2780192828 @default.
- W4243363494 hasConcept C2781364455 @default.
- W4243363494 hasConcept C41091548 @default.
- W4243363494 hasConcept C502942594 @default.
- W4243363494 hasConcept C54355233 @default.
- W4243363494 hasConcept C55493867 @default.
- W4243363494 hasConcept C61367390 @default.
- W4243363494 hasConcept C62112901 @default.
- W4243363494 hasConcept C86803240 @default.
- W4243363494 hasConceptScore W4243363494C104317684 @default.
- W4243363494 hasConceptScore W4243363494C121608353 @default.
- W4243363494 hasConceptScore W4243363494C2776551883 @default.
- W4243363494 hasConceptScore W4243363494C2776745794 @default.
- W4243363494 hasConceptScore W4243363494C2779723316 @default.
- W4243363494 hasConceptScore W4243363494C2780192828 @default.
- W4243363494 hasConceptScore W4243363494C2781364455 @default.
- W4243363494 hasConceptScore W4243363494C41091548 @default.
- W4243363494 hasConceptScore W4243363494C502942594 @default.
- W4243363494 hasConceptScore W4243363494C54355233 @default.
- W4243363494 hasConceptScore W4243363494C55493867 @default.
- W4243363494 hasConceptScore W4243363494C61367390 @default.
- W4243363494 hasConceptScore W4243363494C62112901 @default.
- W4243363494 hasConceptScore W4243363494C86803240 @default.
- W4243363494 hasLocation W42433634941 @default.
- W4243363494 hasOpenAccess W4243363494 @default.
- W4243363494 hasPrimaryLocation W42433634941 @default.
- W4243363494 hasRelatedWork W11750182 @default.
- W4243363494 hasRelatedWork W20638054 @default.
- W4243363494 hasRelatedWork W31455466 @default.
- W4243363494 hasRelatedWork W32982348 @default.
- W4243363494 hasRelatedWork W35336205 @default.
- W4243363494 hasRelatedWork W35748098 @default.
- W4243363494 hasRelatedWork W36716975 @default.
- W4243363494 hasRelatedWork W38577244 @default.
- W4243363494 hasRelatedWork W421584 @default.
- W4243363494 hasRelatedWork W8802154 @default.
- W4243363494 isParatext "false" @default.
- W4243363494 isRetracted "false" @default.
- W4243363494 workType "article" @default.